MASI Key Statistics, Chart & Performance
The current stock price of MASI is 144.02 USD. In the past month the price increased by 2.4%. In the past year, price decreased by -15.18%.
MASI Latest News, Press Relases and Analysis
MASI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.65 | 222.59B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.9 | 201.13B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.24 | 149.74B | ||
| SYK | STRYKER CORP | 28.27 | 142.38B | ||
| IDXX | IDEXX LABORATORIES INC | 57.81 | 58.21B | ||
| BDX | BECTON DICKINSON AND CO | 13.3 | 54.98B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.18 | 49.48B | ||
| RMD | RESMED INC | 25.09 | 36.26B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.26 | 36.10B | ||
| DXCM | DEXCOM INC | 34.15 | 24.77B | ||
| PODD | INSULET CORP | 68.02 | 21.87B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.71 | 18.78B |
Related stock screener links
About MASI
Company Profile
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Company Info
MASIMO CORP
52 Discovery
Irvine CALIFORNIA 92618 US
CEO: Joe Kiani
Employees: 3600
Phone: 19492977000
MASIMO CORP / MASI FAQ
What does MASI do?
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
What is the current price of MASI stock?
The current stock price of MASI is 144.02 USD. The price increased by 1.12% in the last trading session.
What is the dividend status of MASIMO CORP?
MASI does not pay a dividend.
How is the ChartMill rating for MASIMO CORP?
MASI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for MASI stock?
15 analysts have analysed MASI and the average price target is 188.1 USD. This implies a price increase of 30.61% is expected in the next year compared to the current price of 144.02.
Can you provide the market cap for MASIMO CORP?
MASIMO CORP (MASI) has a market capitalization of 7.74B USD. This makes MASI a Mid Cap stock.
MASI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MASI. When comparing the yearly performance of all stocks, MASI is a bad performer in the overall market: 73.32% of all stocks are doing better.
MASI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MASI. MASI has an average financial health and profitability rating.
MASI Financial Highlights
Over the last trailing twelve months MASI reported a non-GAAP Earnings per Share(EPS) of 5.68. The EPS increased by 54.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.33% | ||
| ROE | -70.3% | ||
| Debt/Equity | 0.69 |
MASI Forecast & Estimates
15 analysts have analysed MASI and the average price target is 188.1 USD. This implies a price increase of 30.61% is expected in the next year compared to the current price of 144.02.
For the next year, analysts expect an EPS growth of 27.12% and a revenue growth -27.11% for MASI